Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Loxo: III Trial of Fixed Pirtobrutinib + Vene and Rituximab vs Vene + Rituximab in CLL/SLL
Clinical Trial Grant
Duke Scholars
Principal Investigator
Andrea Sitlinger
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Loxo Oncology, Inc.
Start Date
March 25, 2022
End Date
March 13, 2027
Awarded By
Loxo Oncology, Inc.
Start Date
March 25, 2022
End Date
March 13, 2027
